Official Title
Role of Famotidine in the Clinical Recovery and Symptomatic Improvement of COVID-19 Patients.
Brief Summary

This study is aimed to investigate the effect of Famotidine in the clinical recovery of COVID-19 patients. COVID19 is a worldwide pandemic. Hence SARS-CoV-2 is a novel virus; there is no specific medication against it. Like other countries of the world, Besides antiviral drugs, immunosuppressive agents, and symptomatic therapy like H2 receptor blocker FAMOTIDINE came to the limelight due to its role in reducing the symptoms of COVID-19 patients. The study will include COVID-19 participants to confirm by RT PCR or an HRCT chest. Detail history of each participant with comorbidity will be taken and will be examined carefully. The hospitalized patients admitted to the HDU/ICU units will be enrolled in this study. Critically ill patients who require ventilator support will not be included in this study. The outcome of the Famotidine treatment will be evaluated and compared with a control group.

Completed
COVID19

Drug: Famotidine 20 MG

Famotidine; tablet Famotac 20mg oral form.
Other Name: Famotac 20mg

Eligibility Criteria

Inclusion Criteria:

- SARS-CoV-2 infection confirmed by RT PCR or CT Chest.

- Severe COVID-19 patients require hospitalization under HDU/ICU.

Exclusion Criteria:

- Patients with severe and/or uncontrolled medical conditions with significantly
compromised organ function.

- Patients who were hospitalized from the before due to other reasons.

- Contraindication / possible drug interaction with Famotidine with existing therapy.

- Immunocompromised patients.

- Pregnancy, Pulmonary Tuberculosis, AIDS

Eligibility Gender
All
Eligibility Age
Minimum: 16 Years ~ Maximum: 80 Years
Countries
Bangladesh
Locations

Chattogram General Hospital
Chittagong, Bangladesh

M. Abdur Rahim Medical College Hospital
Dinājpur, Bangladesh

Abu Taiub Mohammed Mohiuddin Chowdhury, MBBS, MD, Study Chair
First Affiliated Hospital Xi'an Jiaotong University

Chattogram General Hospital
NCT Number
Keywords
COVID 19
Famotidine
Bangladesh
MeSH Terms
COVID-19
Famotidine